Global Intravenous Immunoglobulin Market

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2021

Global Intravenous Immunoglobulin Market

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2021


Discover the latest insights into the booming Intravenous Immunoglobulin (IVIg) Market. This report analyzes market size, growth trends (CAGR ), key players, and regional performance, offering valuable data for investors and industry professionals. Explore market drivers, restraints, and future projections for -.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Intravenous Immunoglobulin (IVIg) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Intravenous Immunoglobulin (IVIg) Market Overview:

Global Intravenous Immunoglobulin (IVIg) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Intravenous Immunoglobulin (IVIg) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Intravenous Immunoglobulin (IVIg) Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Intravenous Immunoglobulin (IVIg) market in 2020.

Global Intravenous Immunoglobulin (IVIg) Market Segmentation

By Type, Intravenous Immunoglobulin (IVIg) market has been segmented into:

IVIg Liquid

IVIg Powder

By Application, Intravenous Immunoglobulin (IVIg) market has been segmented into:

Immunodeficiency

Autoimmune Disease

Acute Infection

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Intravenous Immunoglobulin (IVIg) market are:

Baxter

Grifols

CSL

Octapharma

Biotest

Kedrion

Hualan Bio

CNBG

Shanghai RAAS

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

1. Market Overview of Intravenous Immunoglobulin (IVIg)

1.1 Intravenous Immunoglobulin (IVIg) Market Overview

1.1.1 Intravenous Immunoglobulin (IVIg) Product Scope

1.1.2 Market Status and Outlook

1.2 Intravenous Immunoglobulin (IVIg) Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Intravenous Immunoglobulin (IVIg) Historic Market Size by Regions (2015-2020)

1.4 Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Intravenous Immunoglobulin (IVIg) Sales Market by Type (2015-2026)

2.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Size by Type (2015-2020)

2.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Type (2021-2026)

2.3 IVIg Liquid

2.4 IVIg Powder

3. Covid-19 Impact Intravenous Immunoglobulin (IVIg) Sales Market by Application (2015-2026)

3.1 Global Intravenous Immunoglobulin (IVIg) Historic Market Size by Application (2015-2020)

3.2 Global Intravenous Immunoglobulin (IVIg) Forecasted Market Size by Application (2021-2026)

3.3 Immunodeficiency

3.4 Autoimmune Disease

3.5 Acute Infection

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Intravenous Immunoglobulin (IVIg) Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business

5.1 Baxter

5.1.1 Baxter Company Profile

5.1.2 Baxter Intravenous Immunoglobulin (IVIg) Product Specification

5.1.3 Baxter Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Grifols

5.2.1 Grifols Company Profile

5.2.2 Grifols Intravenous Immunoglobulin (IVIg) Product Specification

5.2.3 Grifols Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 CSL

5.3.1 CSL Company Profile

5.3.2 CSL Intravenous Immunoglobulin (IVIg) Product Specification

5.3.3 CSL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Octapharma

5.4.1 Octapharma Company Profile

5.4.2 Octapharma Intravenous Immunoglobulin (IVIg) Product Specification

5.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Biotest

5.5.1 Biotest Company Profile

5.5.2 Biotest Intravenous Immunoglobulin (IVIg) Product Specification

5.5.3 Biotest Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Kedrion

5.6.1 Kedrion Company Profile

5.6.2 Kedrion Intravenous Immunoglobulin (IVIg) Product Specification

5.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Hualan Bio

5.7.1 Hualan Bio Company Profile

5.7.2 Hualan Bio Intravenous Immunoglobulin (IVIg) Product Specification

5.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 CNBG

5.8.1 CNBG Company Profile

5.8.2 CNBG Intravenous Immunoglobulin (IVIg) Product Specification

5.8.3 CNBG Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Shanghai RAAS

5.9.1 Shanghai RAAS Company Profile

5.9.2 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product Specification

5.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 CBPO

5.10.1 CBPO Company Profile

5.10.2 CBPO Intravenous Immunoglobulin (IVIg) Product Specification

5.10.3 CBPO Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 LFB Group

5.11.1 LFB Group Company Profile

5.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Product Specification

5.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 BPL

5.12.1 BPL Company Profile

5.12.2 BPL Intravenous Immunoglobulin (IVIg) Product Specification

5.12.3 BPL Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Sichuan Yuanda Shuyang

5.13.1 Sichuan Yuanda Shuyang Company Profile

5.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product Specification

5.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

6.2 North America Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

6.3 North America Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

6.4 North America Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

7.2 East Asia Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

7.3 East Asia Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

7.4 East Asia Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

8. Europe

8.1 Europe Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

8.2 Europe Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

8.3 Europe Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

8.4 Europe Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

9.2 South Asia Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

9.3 South Asia Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

9.4 South Asia Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

10.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

10.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

10.4 Southeast Asia Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

11.2 Middle East Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

11.3 Middle East Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

11.4 Middle East Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

12. Africa

12.1 Africa Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

12.2 Africa Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

12.3 Africa Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

12.4 Africa Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

13.2 Oceania Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

13.3 Oceania Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

13.4 Oceania Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

14. South America

14.1 South America Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

14.2 South America Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

14.3 South America Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

14.4 South America Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Intravenous Immunoglobulin (IVIg) Market Size (2015-2026)

15.2 Rest of the World Intravenous Immunoglobulin (IVIg) Key Players in North America (2015-2020)

15.3 Rest of the World Intravenous Immunoglobulin (IVIg) Market Size by Type (2015-2020)

15.4 Rest of the World Intravenous Immunoglobulin (IVIg) Market Size by Application (2015-2020)

16 Intravenous Immunoglobulin (IVIg) Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Intravenous Immunoglobulin (IVIg) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Intravenous Immunoglobulin (IVIg) Market?
Some of the finest and top-notch companies pioneering the Intravenous Immunoglobulin (IVIg) Market are Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang.
What trends are influencing the growth of the Intravenous Immunoglobulin (IVIg) Market?
New players are entering the Intravenous Immunoglobulin (IVIg) Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
What are the major applications for Intravenous Immunoglobulin (IVIg)?
Intravenous Immunoglobulin (IVIg) has a wide range of applications, including and others.
How big is the Intravenous Immunoglobulin (IVIg) Market by 2030?
It is expected that the Intravenous Immunoglobulin (IVIg) Market will reach USD XX million by 2030.
What are the underlying opportunities in the Intravenous Immunoglobulin (IVIg) Market?
The influx of capital into the Intravenous Immunoglobulin (IVIg) Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What are the primary data sources used to evaluate the Intravenous Immunoglobulin (IVIg) Market sizing?
The majority of data for the Intravenous Immunoglobulin (IVIg) Industry is gathered through primary sources, which include interviews and surveys with industry experts from the core and related industries involved in the supply chain. Secondary sources, such as SEC filings, annual reports, whitepapers, and press releases, are also used.